The global sepsis diagnostic market was valued at US$ -- in 2018 and increasing at a significant CAGR over the forecast timeframe owing to surge in the incidence of sepsis, increasing occurrence of different antibiotic-resistant bacterial strains, growing healthcare awareness and health care spending, increasing number of surgical processes and rise in the number of product approvals for sepsis diagnosis are expected to drive the global sepsis diagnostic market.

Global sepsis diagnostic market segmented on the basis of Technology, Product, Pathogen, Type of Analysis, End User, and Geography.

For request sample: [URL]https://www.precisionbusinessinsights.com/request-sample/?product_id=36257[/URL]

Microbiology Dominates the Global Sepsis Diagnostic Market

Based on technology of sepsis diagnosis, global sepsis diagnostic market segmented into Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry. Microbiology dominated the global sepsis diagnostic market in 2018 and estimated to dominate over the forecast period,

North America Leads the Global Sepsis Diagnostic Market

PBI’s global sepsis diagnostic market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2014-2018

Launch of newer technologies of needle free injector products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

Global sepsis diagnostic market further reveals that the key players increasingly adopting strategies such as launch of newer technologies of needle free injector products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.

Key player’s profiles in the report are

• Roche Diagnostics (Switzerland)

• Becton, Dickinson and Company (U.S.)

• Abbott (US)

• bioMérieux (France)

• Danaher (US)

• Luminex (US)

• Immunexpress (US)

• Cepheid Inc (United States)

• Bruker (U.S)

• Quidel Corporation (U.S.)

Detailed Segmentation

By Technology

• Microbiology

• Molecular Diagnostics

• Immunoassays

• Flow Cytometry

By product

• Blood Culture Media

• Instruments

• Assays & Reagents

By Pathogen

• Bacterial Sepsis

• Gram-negative Bacterial Sepsis

• Gram-positive Bacterial Sepsis

• Fungal Sepsis

• Others

Type Analysis

• Laboratory Tests

• Point-Of-Care Tests

By End User

• Hospitals & Clinics

• Home Care Settings

• Research laboratories

• Others

Geography

• North America

? U.S

• Canada

• Europe

• Germany

• France

• U.K

• Italy

• Spain

• Russia

• Poland

• Rest of Europe

• Asia-Pacific

• Japan

• China

• India

• Australia & New Zealand

• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)

• South Korea

• Rest of Asia-Pacific

• Latin America

• Brazil

• Mexico

• Argentina

• Venezuela

• Rest of Latin America

• Middle East and Africa (MEA)

• Gulf Cooperation Council (GCC) Countries

• Israel

• South Africa

• Rest of MEA

For more information: [URL]https://www.precisionbusinessinsights.com/market-reports/global-sepsis-diagnostic-market[/URL]